SDG 3. GOOD HEALTH & WELL-BEING AbSci

Absci’s IPO reflects booming biotech market and growing PNW life sciences industry

July 12, 2021, by Charlotte Schubert

Absci researchers at the company’s HQ in Vancouver, Wash. (Absci photo) The upcoming public offering for Vancouver, Wash.-based biotech company Absci reflects a soaring IPO ...

Read more on GeekWire


SDG 3. GOOD HEALTH & WELL-BEING AbSci

Biotech startup AbSci raises $125M for ‘Protein Printing’ tech; total funding up to $230M

March 23, 2021, by Taylor Soper

AbSci CEO and founder Sean McClain. (AbSci Photo) New funding: Vancouver, Wash.-based biotech company AbSci raised $125 million in a round led by Casdin Capital and ...

Read more on GeekWire


SDG 3. GOOD HEALTH & WELL-BEING DRUG DISCOVERY AbSci

Synthetic Biology Startup Acquires AI Platform To Disrupt The Drug Industry

February 5, 2021, by John Cumbers, Contributor

Synthetic biology company AbSci’s recent acquisition of the artificial intelligence platform, Denovium, could help get novel therapeutics to patients more quickly

Read more on Forbes - Business